Skip to main content
Premium Trial:

Request an Annual Quote

GenoSpectra, Robert Bird, Fuji Photo Film Co., Maven Technologies


GenoSpectra has received US Patent No. 6,594,432, “Microarray fabrication techniques and apparatus.” The patent covers a system and method for printing micro- arrays that has a printhead comprised of capillary bundles. These bundles can be random, and can provide a large number of probes on the surface. The patent also covers methods and equipment to detect defective microarrays that are missing probes.


Robert Bird, of Rockville, Md., has been awarded US Patent No. 6,593,084, “Carcinogen assay.” The patent refers to assays and methods to determine whether a specific agent is a carcinogen. These methods involve correlating differential gene expression patterns in mammalian cells treated with the agent to those treated with known carcinogens. The invention also specifies methods for using DNA and RNA isolated from these cells, and for determining whether an agent is a carcinogen by measuring protein synthesis or post-translational modifications of proteins in mammalian cells treated with the test agent, and comparing them to the post-translational modifications and protein synthesis in cells treated with known carcinogens.


Fuji Photo Film Co. has received US Patent No. 6,592,819, “Microarray chip manufacturing apparatus.” The patent covers an apparatus for manufacturing microarrays using picking pins to pick binding substances that are arranged either linearly or on two-dimensional patterns on a picking surface, and to spot these onto a chip with narrower dimensions than the original arrangements. The invention stipulates that the pins are movable, to enable changing of the spaces between them, as it moves from the picking surface to the chip.


Maven Technologies has received US Patent No. 6,594,011, “Imaging apparatus and method.” In the method, a light beam is passed through what is called a “total internal reflection” structure, and a genetic, other biological, or chemical sample is placed at the point of the total reflection for detection.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.